← Leaderboards
Kent G Benner
Oregon Health And Science University
$574,215
Attributed
$574,215
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$574,215 · 3
By mechanism
M01$574,215 · 3
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Lissi Hansen$2,525,347
- Craig R Nichols$571,817
- Dennis J Chia$1,000,518
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationClinical ResearchDrug Screening /EvaluationClinical TrialsLiver CirrhosisBiliary Tract Disorder ChemotherapyMethotrexateCombination ChemotherapyPrimary Biliary CirrhosisLongitudinal Human StudyUrsodeoxycholateOctreotidePortal HypertensionQuality Of LifeHemorrhageBlood ChemistryBlood Flow MeasurementBlood PressureCardiovascular Disorder ChemotherapyCardiovascular Shunt SurgeryDiureticsEsophageal VaricesHealth Care Cost /Financing
Grant awards (11)
URSODEOXYCHOLATE-METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS$8,706
M01 · FY2005 · RR
Ursodeoxycholate-Methotrexate for Treatment of Primary Biliary Cirrhosis$48,276
M01 · FY2004 · RR
Study of sandostatin LAR in patients with cirrhosis$172,411
M01 · FY2001 · RR
NORTH AMERICAN STUDY OF TREATMENT FOR REFRACTORY ASCITES (NASTRA)$172,411
M01 · FY2001 · RR
URSODEOXYCHOLATE/METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS$172,411
M01 · FY2001 · RR
NORTH AMERICAN STUDY OF TREATMENT FOR REFRACTORY ASCITES (NASTRA)$0
M01 · FY2001 · RR
URSODEOXYCHOLATE/METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS$0
M01 · FY2001 · RR
Study of sandostatin LAR in patients with cirrhosis$0
M01 · FY2001 · RR
URSODEOXYCHOLATE/METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS$0
M01 · FY2000 · RR
Study of sandostatin LAR in patients with cirrhosis$0
M01 · FY2000 · RR
NORTH AMERICAN STUDY OF TREATMENT FOR REFRACTORY ASCITES (NASTRA)$0
M01 · FY2000 · RR